ClinicaliQ Trial Snapshot
- Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry — Active Not Recruiting • NCT04907240.
- Registry tracking real-world outcomes in patients receiving Gore Viabahn stent grafts with bioactive surface coating.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Collect real-world post-market clinical follow-up data on patients treated with the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX) Conditions: Peripheral Artery Disease, Popliteal Aneurysm, Hemodialysis Access, Visceral Artery Aneurysms, Trauma Injury Interventions: GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX) Lead Sponsor: W.L.Gore & Associates Planned Enrollment: 614 participants